Novel Therapeutic Strategies in Myeloma – Module 4

Access Activity

Overview / Abstract:

Target Audience

This activity is designed to meet the educational needs of hematologists, oncologists, and other healthcare professionals involved in the diagnosis and treatment of patients with blood cancers.

Program Overview

This activity provides an overview of recent therapeutic advances for patients with newly diagnosed or relapsed multiple myeloma and the mechanisms by which novel therapies work.

Learning Objective

Upon completion of this activity, participants should be better able to:

Assess how novel therapeutic strategies lead to improved survival in myeloma


Mar 02, 2023


Physician CME



Credits / Hours

0.5 AMA PRA Category 1 Credit(s)™



Presenters / Authors / Faculty


Kenneth C. Anderson, MD
Kraft Family Professor of Medicine
Harvard Medical School
Program Director, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, MA

Sponsors / Supporters / Grant Providers

The Leukemia & Lymphoma Society

Keywords / Search Terms

Relias LLC Relias LLC. FreeCME., Myeloma Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map